Hyperprolactinemia: etiology, diagnosis, and management - PubMed

Review

Hyperprolactinemia: etiology, diagnosis, and management

Peak Mann Mah et al. Semin Reprod Med. 2002 Nov.

Abstract

Hyperprolactinemia is the most common endocrine disorder of the hypothalamic-pituitary axis. A prolactinoma is the most common cause of chronic hyperprolactinemia once pregnancy, primary hypothyroidism, and drugs that elevate serum prolactin levels have been excluded. Patients can present with hypogonadism, infertility, galactorrhea, osteopenia, and mass effects of the tumor. When hyperprolactinemia is confirmed, a cause for the disorder needs to be sought. This involves a careful history and examination, followed by laboratory tests and diagnostic imaging of the sella turcica. The goals of treatment are to normalize prolactin levels, restore gonadal function, and reduce the effects of chronic hyperprolactinemia. Dopamine agonists are the treatment of choice for the majority of patients. Transsphenoidal surgery is usually reserved for patients who are intolerant of or resistant to dopamine agonists or when hyperprolactinemia is caused by non-prolactin-secreting tumors compressing the pituitary stalk. Cabergoline has been shown to be more effective and better tolerated than bromocriptine. However, there are more data on the safety of the latter drug during pregnancy and bromocriptine, therefore, remains the treatment of choice in hyperprolactinemic women wishing to conceive.

Similar articles

• Hyperprolactinemia.

  Biller BM. Biller BM. Int J Fertil Womens Med. 1999 Mar-Apr;44(2):74-7. Int J Fertil Womens Med. 1999. PMID: 10338264 Review.

• Hyperprolactinemia: pathophysiology and management.

  Verhelst J, Abs R. Verhelst J, et al. Treat Endocrinol. 2003;2(1):23-32. doi: 10.2165/00024677-200302010-00003. Treat Endocrinol. 2003. PMID: 15871552 Review.

• Current treatment issues in female hyperprolactinaemia.

  Crosignani PG. Crosignani PG. Eur J Obstet Gynecol Reprod Biol. 2006 Apr 1;125(2):152-64. doi: 10.1016/j.ejogrb.2005.10.005. Epub 2005 Nov 9. Eur J Obstet Gynecol Reprod Biol. 2006. PMID: 16288952 Review.

• Guidelines for the diagnosis and treatment of hyperprolactinemia.

  Biller BM, Luciano A, Crosignani PG, Molitch M, Olive D, Rebar R, Sanfilippo J, Webster J, Zacur H. Biller BM, et al. J Reprod Med. 1999 Dec;44(12 Suppl):1075-84. J Reprod Med. 1999. PMID: 10649814

• Diagnostic evaluation of hyperprolactinemia.

  Biller BM. Biller BM. J Reprod Med. 1999 Dec;44(12 Suppl):1095-9. J Reprod Med. 1999. PMID: 10649817

Cited by

• Molecular basis for catecholaminergic neuron diversity.

  Grimm J, Mueller A, Hefti F, Rosenthal A. Grimm J, et al. Proc Natl Acad Sci U S A. 2004 Sep 21;101(38):13891-6. doi: 10.1073/pnas.0405340101. Epub 2004 Sep 7. Proc Natl Acad Sci U S A. 2004. PMID: 15353588 Free PMC article.

• Hyperprolactinemia with normal serum prolactin: Its clinical significance.

  Agarwal M, Das A, Singh SA. Agarwal M, et al. J Hum Reprod Sci. 2010 May;3(2):111-2. doi: 10.4103/0974-1208.69334. J Hum Reprod Sci. 2010. PMID: 21209758 Free PMC article.

• Effects of Anterior Pituitary Adenomas' Hormones on Glucose Metabolism and Its Clinical Implications.

  Li M, Zhang J, Yang G, Zhang J, Han M, Zhang Y, Liu Y. Li M, et al. Diabetes Metab Syndr Obes. 2023 Feb 13;16:409-424. doi: 10.2147/DMSO.S397445. eCollection 2023. Diabetes Metab Syndr Obes. 2023. PMID: 36816815 Free PMC article. Review.

• An assessment of serum prolactin levels among infertile women with galactorrhea attending a gynecological clinic North-West Nigeria.

  Ugwa EA, Ashimi AO, Abubakar MY, Takai IU, Lukman OT, Lawal HA, Also MA, Gift AN, Kiri HM. Ugwa EA, et al. Niger Med J. 2016 May-Jun;57(3):178-81. doi: 10.4103/0300-1652.184068. Niger Med J. 2016. PMID: 27397959 Free PMC article.

• Prolactin and oxytocin: potential targets for migraine treatment.

  Szewczyk AK, Ulutas S, Aktürk T, Al-Hassany L, Börner C, Cernigliaro F, Kodounis M, Lo Cascio S, Mikolajek D, Onan D, Ragaglini C, Ratti S, Rivera-Mancilla E, Tsanoula S, Villino R, Messlinger K, Maassen Van Den Brink A, de Vries T; European Headache Federation School of Advanced Studies (EHF-SAS). Szewczyk AK, et al. J Headache Pain. 2023 Mar 27;24(1):31. doi: 10.1186/s10194-023-01557-6. J Headache Pain. 2023. PMID: 36967387 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Georg Thieme Verlag Stuttgart, New York
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database